These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 26052403)

  • 1. Management of recurrent hepatocellular carcinoma after liver transplant.
    Chok KSh
    World J Hepatol; 2015 May; 7(8):1142-8. PubMed ID: 26052403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current status of therapy for hepatocellular carcinoma.
    Corey KE; Pratt DS
    Therap Adv Gastroenterol; 2009 Jan; 2(1):45-57. PubMed ID: 21180533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loco-regional therapies for patients with hepatocellular carcinoma awaiting liver transplantation: Selecting an optimal therapy.
    Byrne TJ; Rakela J
    World J Transplant; 2016 Jun; 6(2):306-13. PubMed ID: 27358775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic liver transplantation for high-risk recurrent hepatocellular carcinoma.
    Yang PC; Ho CM; Hu RH; Ho MC; Wu YM; Lee PH
    World J Hepatol; 2016 Nov; 8(31):1309-1317. PubMed ID: 27872682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon's perspective.
    Poon RT; Fan ST; Tsang FH; Wong J
    Ann Surg; 2002 Apr; 235(4):466-86. PubMed ID: 11923602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase 2 study of stereotactic body radiotherapy and optional transarterial chemoembolization for solitary hepatocellular carcinoma not amenable to resection and radiofrequency ablation.
    Takeda A; Sanuki N; Tsurugai Y; Iwabuchi S; Matsunaga K; Ebinuma H; Imajo K; Aoki Y; Saito H; Kunieda E
    Cancer; 2016 Jul; 122(13):2041-9. PubMed ID: 27062278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Goals and targets for personalized therapy for HCC.
    Couri T; Pillai A
    Hepatol Int; 2019 Mar; 13(2):125-137. PubMed ID: 30600478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonsurgical multidisciplinary approach for recurrent hepatocellular carcinoma after surgical resection.
    Kim KM
    Hepat Oncol; 2015 Jan; 2(1):29-38. PubMed ID: 30190985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapies for patients with hepatocellular carcinoma awaiting liver transplantation: A systematic review and meta-analysis.
    Kulik L; Heimbach JK; Zaiem F; Almasri J; Prokop LJ; Wang Z; Murad MH; Mohammed K
    Hepatology; 2018 Jan; 67(1):381-400. PubMed ID: 28859222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy?
    Adam R; Azoulay D; Castaing D; Eshkenazy R; Pascal G; Hashizume K; Samuel D; Bismuth H
    Ann Surg; 2003 Oct; 238(4):508-18; discussion 518-9. PubMed ID: 14530722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver Resection versus Radiofrequency Ablation plus Transcatheter Arterial Chemoembolization in Cirrhotic Patients with Solitary Large Hepatocellular Carcinoma.
    Saviano A; Iezzi R; Giuliante F; Salvatore L; Mele C; Posa A; Ardito F; De Gaetano AM; Pompili M;
    J Vasc Interv Radiol; 2017 Nov; 28(11):1512-1519. PubMed ID: 28734848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiofrequency ablation and transarterial chemoembolisation as first-line treatment for recurrent hepatocellular carcinoma or isolated intrahepatic recurrent hepatocellular carcinoma in transplanted livers.
    Kim SS; Kang TW; Song KD; Cho SK; Lee MW; Rhim H; Sinn DH; Jung SH
    Clin Radiol; 2017 Feb; 72(2):141-149. PubMed ID: 27742104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current surgical treatment strategies for hepatocellular carcinoma in North America.
    Khan AS; Fowler KJ; Chapman WC
    World J Gastroenterol; 2014 Nov; 20(41):15007-17. PubMed ID: 25386049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-Term Outcomes of Transarterial Chemoembolization Combined with Radiofrequency Ablation Versus Transarterial Chemoembolization Alone for Recurrent Hepatocellular Carcinoma After Surgical Resection.
    Song Q; Ren W; Fan L; Zhao M; Mao L; Jiang S; Zhao C; Cui Y
    Dig Dis Sci; 2020 Apr; 65(4):1266-1275. PubMed ID: 31312995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current management of hepatocellular carcinoma.
    Crissien AM; Frenette C
    Gastroenterol Hepatol (N Y); 2014 Mar; 10(3):153-61. PubMed ID: 24829542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seventeen Years of Pediatric Liver Transplantation Experience for Cirrhosis and Hepatocellular Carcinoma.
    Özçay F; Balci Sezer O; Sarialioğlu F; Boyvat F; Coşkun M; Haberal Reyhan N; Haberal M
    Exp Clin Transplant; 2022 Mar; ():. PubMed ID: 35297328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Concise Review on Current Trends in Imaging and Surgical Management of Hepatocellular Carcinoma.
    Asemota J; Saleh M; Igbinovia O; Burns D
    Cureus; 2020 Jul; 12(7):e9191. PubMed ID: 32818122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver transplantation in the MELD era--analysis of the OPTN/UNOS registry.
    Taniguchi M
    Clin Transpl; 2012; ():41-65. PubMed ID: 23721009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver-Directed Treatment Options Following Liver Tumor Recurrence: A Review of the Literature.
    Aquina CT; Eskander MF; Pawlik TM
    Front Oncol; 2022; 12():832405. PubMed ID: 35174097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic effect of transarterial chemoembolization-induced complete pathological response in patients undergoing liver resection and transplantation for hepatocellular carcinoma.
    Kang WH; Hwang S; Song GW; Lee YJ; Kim KH; Ahn CS; Moon DB; Jung DH; Park GC; Lee SG
    Liver Transpl; 2017 Jun; 23(6):781-790. PubMed ID: 28240808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.